KYOWA KIRIN SUPPORTS RARE DISEASE MONTH

Join us as we celebrate the rarest day of the year, Rare Disease Day (29 February 2024), as we #LightUpforRare and support the hundreds of millions of people and their families living with a rare disease worldwide.

Rare Disease Day (RDD) this year takes place on Thursday 29 February 2024 - the rarest day of the year. RDD was launched in 2008 by EURORDIS and has since become a worldwide phenomenon, with patient organisations in over 100 countries around the world participating each year. The day aims to raise awareness of the importance of equity for the 300 million people living with rare diseases worldwide.

Every year, Kyowa Kirin comes together to mark the event by raising awareness of rare diseases, highlighting the unmet needs of those impacted, and sharing how we are relentlessly working to support the community throughout the year.

Our Global Chain of Lights

Throughout the month of February, we asked Kyowa Kirin colleagues around the world to share images and videos as they #LightUpForRare.

Watch the video to see how our colleagues got on and to see our collective Global Chain of Lights to celebrate RDD on the 29th of February 2024.

Our Commitment to Life

To celebrate RDD this year and throughout the month of February, Kyowa Kirin will join the rare disease community to #LightUpForRare. By showing our global support, we are proudly signaling our commitment and unity to those with under-diagnosed and under-served diseases.

For decades, we have been identifying innovative solutions for diseases that have high unmet medical need. By taking products ‘from Pipeline to Patients’, we aim to utilise our expertise to maximise the impact of our medicines and technologies across multiple disease areas.

We asked our Global Kyowa Kirin leaders how our core value, Commitment to Life, guides us in our mission to bring more smiles to those living with a rare disease.

Living with a rare disease: an insight

There are over 6,000 distinct rare conditions, currently affecting about 300 million people worldwide and it takes approximately five years on average for rare disease patients to get a diagnosis. Rare diseases not only affect patients, but also impact their families, friends, and caretakers. For example, two-thirds of family carers spend more than two hours a day on disease-related tasks and seven in ten reduce or stop their professional activity due to their family member’s rare disease.

Watch the video below to hear more from some of the people we've partnered with around the world who are living with rare diseases.

  • These videos are provided from this global site for the purpose of serving those who reside outside of Japan
KYOWA KIRIN
References:
  • *
    EURORDIS. Rare Disease Day. Available at: https://www.eurordis.org/rare-disease-day/ Accessed January 2024
  • *
    EURORDIS. What is a rare disease? Available at: https://www.eurordis.org/information-support/what-is-a-rare-disease/ Accessed January 2024

More Kyowa Kirin "Patients" Stories

Kyowa Kirin Global Corporate Planning Head Shoko Itagaki’s Message for International Women's Day

People & Culture | March 8, 2024

Kyowa Kirin celebrates Rare Disease Day 2024 across the world

Patients | February 9, 2024

Kyowa Kirin CEO Miyamoto’s New Year Message

Growth | January 9, 2024

Kyowa Kirin Chief International Business Officer Abdul Mullick’s Message on UN’s International Day of Persons with Disabilities

Sustainability | December 1, 2023

Kyowa Kirin hosted a booth for the first time at the Tokyo Rainbow Pride 2023 [Our Diversity, Equity & Inclusion]

People & Culture | November 9, 2023

Our Stable Supply of High-quality Pharmaceuticals

Sustainability | September 20, 2023

Provide pharmaceuticals for unmet medical needs - A Conversation with Kyowa Kirin’s R&D Executives

Innovation | August 22, 2023PDF file

Ensure a Thriving Global Environment for Future Generations

Sustainability | July 28, 2023

“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅡ

People & Culture | June 9, 2023

How Kyowa Kirin Celebrated Rare Disease Day 2023 around The World

Patients | May 18, 2023

“Menstruation” and “fertility treatment” felt like taboo subjects in the workplace - Why be open about issues unique to women? PartⅠ

People & Culture | April 25, 2023

Kyowa Kirin CEO Miyamoto’s Message on Rare Disease Day

Patients | February 28, 2023

Promoting patient advocacy and nurturing patient-centric care: Interview with Kyowa Kirin North America

Patients | February 14, 2023

Celebrating another year of diverse initiatives around the world: RDD 2022 in EMEA

Patients | January 24, 2023

Celebrating another year of diverse initiatives around the world: RDD 2022 in North America

Patients | December 15, 2022

Celebrating another year of diverse initiatives around the world: RDD 2022 in Asia Pacific

Patients | November 21, 2022

Celebrating another year of diverse initiatives around the world: RDD 2022 in Japan

Patients | October 20, 2022

Providing high-quality pharmaceuticals to patients around the world

Sustainability | September 22, 2022

Striving to create life-changing “Only-one value” that brings smiles to patients

Innovation | July 25, 2022

Kyowa Kirin International: It's Time to Shine A Light on XLH

Patients | June 27, 2022

Kyowa Kirin CEO Miyamoto’s Message on Pride Month

People & Culture | June 9, 2022

Kyowa Kirin International Celebrates the UN’s International Day of Persons with Disabilities in EMEA

People & Culture | January 20, 2022

Kyowa Kirin International: Around the world challenge

People & Culture | December 17, 2021Open in new window

Kyowa Kirin North America: Honoring The Caregiver, Everyday Heroes, During National Family Caregivers Month

Patients | November 19, 2021

Kyowa Kirin's Effort to Realize a Sustainable Society

Sustainability | October 11, 2021

Our Financial Strategy for Creating Life-changing Value

Growth | September 9, 2021

Changes in society caused by COVID-19 and the impact on Kyowa Kirin

Growth | August 19, 2021

Bio Adventure Hands-On Experience Sessions: Become a drug discovery researcher During Your Summer Break

Sustainability | July 27, 2021

AMGEN AND KYOWA KIRIN TO JOINTLY DEVELOP AND COMMERCIALIZE KHK4083, A PHASE 3-READY, POTENTIAL FIRST-IN-CLASS TREATMENT FOR ATOPIC DERMATITIS

News Release | June 1, 2021

MEI Pharma and Kyowa Kirin Announce New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting

News Release | May 20, 2021

White Paper on the unrecognized burden of XLH in adults in Europe

Patients | July 13, 2020

Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (First Half)

People & Culture | March 5, 2020

Empowering Children to Ask "Why?": Tohoku University Science Campus Hands-On Science Lessons (Second Half)

People & Culture | March 5, 2020

“Delivering smiles with sports” Creating an inclusive society through table tennis

Sustainability | January 14, 2020

Bio Adventure*: Kyowa Kirin Invites Children to a Science Adventure

People & Culture | July 3, 2019

Return to Stories